Discover your next big idea at PACK EXPO Las Vegas this September
Experience a breakthrough in packaging & processing and transform your business with solutions from 2,300 suppliers spanning all industries.
REGISTER NOW & SAVE

Pharma patent cliff paves the way for new growth

Patent expires and the rise of drug launches are expected to stimulate growth in the pharmaceutical industry with consequent demand for packaging machinery.

Pharma patents
Pharma patents

According to Global Trends Impacting the Market for Packaging Machinery 2018, a new report by PMMI Business Intelligence, the pharmaceutical market has been hurt over the last several years by the expiration of patents for a number of blockbuster drugs – also known as the patent cliff. Though significantly impacting revenues of some of the leading pharmaceutical suppliers who are no longer able to charge a premium for their product, this has also resulted in more competitors entering the market with low-cost products.

The increase in the number of products being sold to the market also increases the number of different packages that are being produced. This trend is expected to continue as several other patents are due to expire in the next few years; an estimated $60 billion of drug sales from leading pharmaceutical companies will be at risk for competition.

The US Food and Drug Administration (FDA) approved 51 new drugs in 2015, the highest number in the past 66 years and second highest on record. This includes breakthrough medicines for heart disease (from Novartis), high cholesterol (from Sanofi and Amgen), cancer (from Merck and Bristol-Myers Squibb), and hepatitis C (from Gilead Sciences). The market has also consolidated in recent years, for example the GSK acquisition of Novartis and Actavis acquiring Allergan (at approximately $66 billion).

Some of these examples are already multi-billion dollar medicines; those that are not yet are expected to reach such levels in the future.

With a number of leading drugs now off-patent, additional acquisitions are expected, such as the 2015 bid by Teva Pharmaceutical Industries Ltd. for US-based, Netherlands-registered Mylan, as large multinationals look to add new technologies and revenue streams.

Download the free Executive Summary, or the full report, at pwgo.to/3551.

Researched List: Engineering Services Firms
Looking for engineering services? Our curated list features 100+ companies specializing in civil, process, structural, and electrical engineering. Many also offer construction, design, and architecture services. Download to access company names, markets served, key services, contact information, and more!
Download Now
Researched List: Engineering Services Firms
Annual Outlook Report: Workforce
Hiring remains a major challenge in packaging, with 78% struggling to fill unskilled roles and 84% lacking experienced workers. As automation grows, companies must rethink hiring and training. Download the full report for key insights.
Download Now
Annual Outlook Report: Workforce